Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 62.94
-0.20 (-0.32%)
At close: Dec 5, 2025
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 28.71 billion as of December 8, 2025. Its market cap has increased by 45.96% in one year.
Market Cap
28.71B
Enterprise Value
27.85B
Revenue
607.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
62.94
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 28.71B, an increase of 74.63%. That is a compound annual growth rate of 15.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 29.03B | 68.40% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 409.56B |
| WuXi AppTec | 269.53B |
| Shenzhen Mindray Bio-Medical Electronics | 244.77B |
| Sichuan Biokin Pharmaceutical | 150.27B |
| Shanghai United Imaging Healthcare | 107.10B |
| Aier Eye Hospital Group | 105.04B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.93B |
| Yunnan Baiyao Group Co.,Ltd | 99.79B |